Login / Signup

A class of hydrazones are active against non-replicating Mycobacterium tuberculosis.

Shilah A BonnettDevon DennisonMegan FilesAnumita BajpaiTanya Parish
Published in: PloS one (2018)
There is an urgent need for the development of shorter, simpler and more tolerable drugs to treat antibiotic tolerant populations of Mycobacterium tuberculosis. We previously identified a series of hydrazones active against M. tuberculosis. We selected five representative compounds for further analysis. All compounds were active against non-replicating M. tuberculosis, with two compounds demonstrating greater activity under hypoxic conditions than aerobic culture. Compounds had bactericidal activity with MBC/MIC of < 4 and demonstrated an inoculum-dependent effect against aerobically replicating bacteria. Bacterial kill kinetics demonstrated a faster rate of kill against non-replicating bacilli generated by nutrient starvation. Compounds had limited activity against other bacterial species. In conclusion, we have demonstrated that hydrazones have some attractive properties in terms of their anti-tubercular activity.
Keyphrases
  • mycobacterium tuberculosis
  • pulmonary tuberculosis
  • emergency department
  • gram negative
  • hepatitis c virus
  • high intensity
  • human immunodeficiency virus
  • data analysis